UP!
| 2016-05-31 | Downgrade | Credit Suisse | Outperform to Neutral | $33.00 to $30.00 |
| 2016-05-31 | Downgrade | Credit Suisse Group AG | Outperform to Neutral | $33.00 to $30.00 |
| 2016-05-27 | Boost Price Target | Citigroup Inc. | Buy | $29.00 to $36.00 |
| 2016-04-08 | Lower Price Target | Morgan Stanley | $71.00 to $70.00 | |
| 2016-03-28 | Reiterated Rating | William Blair | Buy | |
| 2016-03-28 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-03-28 | Downgrade | Goldman Sachs | Buy to Neutral | $65.00 to $30.00 |
| 2016-03-28 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | $65.00 to $30.00 |
| 2016-03-25 | Lower Price Target | Credit Suisse | Outperform | $47.00 to $34.00 |
| 2016-03-25 | Lower Price Target | Cowen and Company | Outperform | $65.00 to $40.00 |
| 2016-03-24 | Reiterated Rating | Cowen and Company | Buy | $65.00 to $40.00 |
| 2016-03-07 | Reiterated Rating | Credit Suisse | Outperform | $59.00 to $47.00 |
| 2016-02-13 | Reiterated Rating | Citigroup Inc. | Buy | |
| 2015-12-17 | Initiated Coverage | Goldman Sachs | Buy | $65.00 |
| 2015-11-20 | Reiterated Rating | Cowen and Company | Buy | $65.00 |
| 2015-11-17 | Boost Price Target | Morgan Stanley | Overweight | $61.00 to $62.00 |
| 2015-08-05 | Reiterated Rating | Cowen and Company | Buy | $45.00 to $65.00 |
| 2015-06-23 | Initiated Coverage | Credit Suisse | Outperform | $51.00 |
| 2015-03-17 | Boost Price Target | Credit Suisse | $51.00 | |
| 2013-11-06 | Lower Price Target | Cowen and Company | Outperform | $47.00 to $45.00 |
| 2016-05-31 | Downgrade | Credit Suisse | Outperform to Neutral | $33.00 to $30.00 |
| 2016-05-31 | Downgrade | Credit Suisse Group AG | Outperform to Neutral | $33.00 to $30.00 |
| 2016-05-27 | Boost Price Target | Citigroup Inc. | Buy | $29.00 to $36.00 |
| 2016-04-08 | Lower Price Target | Morgan Stanley | $71.00 to $70.00 | |
| 2016-03-28 | Reiterated Rating | William Blair | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PTLA 24 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 2.31M |
| BlackRock Institutional Trust Company, N.A. | 1.47M |
| Elk Creek Partners, LLC | 0.75M |
| WEATHERBIE CAPITAL, LLC | 0.60M |
| BlackRock Investment Management, LLC | 0.18M |
| TEACHERS ADVISORS INC | 0.16M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.12M |
| BLACKROCK ADVISORS LLC | 96028 |
| MANAGED ACCOUNT ADVISORS LLC | 86077 |
| COWEN GROUP, INC. | 63500 |
| BlackRock Group LTD | 45968 |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 22914 |
| BB&T SECURITIES, LLC | 20854 |
| BOSTON ADVISORS LLC | 17738 |
| Airain ltd | 13643 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Fullerton Management Pte Ltd | 15.90% (6583568) | PTLA / |
| Maxwell (Mauritius) Pte Ltd | 9.99% (4133568) | AMRS / PTLA / |
| HIRSCH RUSSELL C | 4.32% (1788647) | BAXS / PTLA / |
| Topper James N | 3.45% (1428954) | FOLD / LJPC / PTLA / |
| Lis William Chief Executive Officer | 0.17% (70624) | PTLA / |
| Dier Mardi Senior VP and CFO | 0.15% (61442) | ADMS / PTLA / |
| CHAMPSI FARAH | 0.07% (27507) | CMRX / KITE / PTLA / TRVN / |
| Moriarty John B EVP, General Counsel | 0.06% (25000) | PTLA / |
| Fu Tao EVP, CBO | 0.04% (18346) | PTLA / |
| Phillips Peggy V | 0.03% (14134) | DVAX / PTLA / PZRX / TKMR / |
| George Jean | 0.02% (8632) | CALA / PTLA / XLRN / ZLTQ / |
| Lawrence John H III SVP, Chief Medical Officer | 0.02% (6875) | PTLA / |
| BIRD JEFFREY W | 0.01% (6000) | CORT / CRDC / MATR / PTLA / THLD / |
| Curnutte John T Executive Vice President | 0.01% (5049) | PTLA / |
| JOHNSON JOHN | 0.01% (3000) | AVEO / CEMP / DNDN / OCRX / PTLA / SCMP / |
| Brege Laura | 0.01% (3000) | ACAD / DCTH / DVAX / PCRX / PETX / PTLA / |
| FENTON DENNIS M | 0.01% (3000) | DNDN / HSP / KYTH / PTLA / XNPT / |
| RENTON HOLLINGS | 0.01% (3000) | AFFY / CPHD / KYTH / PTLA / RIGL / |
| STUMP DAVID C | 0.01% (3000) | DNDN / MGNX / PTLA / SNSS / |
UM